Tetrahydrodeoxycorticosterone

Tetrahydrodeoxycorticosterone (abbreviated as THDOC; 3α,21-dihydroxy-5α-pregnan-20-one), also referred to as allotetrahydrocorticosterone, is an endogenous neurosteroid.^[1] It is synthesized from the adrenal hormone deoxycorticosterone by the action of two enzymes, 5α-reductase type I and 3α-hydroxysteroid dehydrogenase.^[2] THDOC is a potent positive allosteric modulator of the GABA_A receptor, and has sedative, anxiolytic and anticonvulsant effects.^[3][4][5] Changes in the normal levels of this steroid particularly during pregnancy and menstruation may be involved in some types of epilepsy (catamenial epilepsy) and premenstrual syndrome,^[6] as well as stress, anxiety and depression.^{[7][8][9][10][11]}

Other namesTHDOC

CAS Number

• 567-03-3 ^Y

PubChem CID

• 91475

UNII

• 4AB717DP4A

Quick facts Clinical data, Other names ...

Tetrahydrodeoxycorticosterone

Clinical data
Other names	THDOC
Identifiers
IUPAC name (3α,5β)-3,21-dihydroxypregnan-20-one
CAS Number	567-03-3 Y
PubChem CID	91475
UNII	4AB717DP4A
ECHA InfoCard	100.008.457
Chemical and physical data
Formula	C21H34O3
Molar mass	334.500 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@]12CCC(C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O
(verify)

Close